RICHARD RUGGIERI: Open Payments
NPI 1700883055 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,533 in 179 payments from 24 companies in 2025. Trend: 2023 $4,425 · 2024 $3,660 · 2025 $3,533
Food & beverage: $3,533
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 24 | $461 |
| ABBVIE INC. | 29 | $436 |
| AstraZeneca Pharmaceuticals LP | 19 | $411 |
| Lundbeck LLC | 15 | $367 |
| GlaxoSmithKline, LLC. | 11 | $234 |
| Novo Nordisk Inc | 11 | $232 |
| Lilly USA, LLC | 8 | $185 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $143 |
| Alnylam Pharmaceuticals Inc. | 10 | $139 |
Products named: REXULTI, ELIQUIS, PREVNAR 20, VRAYLAR, FARXIGA, MOUNJARO, TRELEGY ELLIPTA, JARDIANCE.
Industry payments across RI — which companies pay providers there.
